Enteric Softgel Capsules Market by Application (Health Supplements and Pharmaceuticals), and Sales Channel (Supermarket & Hypermarket, Pharmacy & Drug Store, and Online Provider): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
- ALL2831903
- 151 Pages
- December 2018
- Pharmaceuticals
Enteric Softgel Capsules Market Overview:
The global enteric softgel capsules market generated $1,851 million in 2017, and is projected to reach $2,589 million by 2025, registering a CAGR of 4.2% from 2018 to 2025. Soft capsules are a single-unit solid dosage form, consisting of a liquid or semi-solid drug or extract within a soft shell. Enteric softgel capsules are a form of delayed release dosage forms, which protect either the drugs from the acidity of the stomach, or the stomach from the detrimental effects of the drug.
The global enteric softgel capsules market is expected to grow at a significant rate during the forecast period, owing to growth in number of R&D activities to increase bioavailability of the drug, surge in demand for softgel health supplements, rise in consumer awareness related to preventative healthcare, and proliferation of distribution channels. Further, improvement in lifestyle pattern, rise in geriatric population, and increase in number of self-directed consumers have fueled the market growth. However, stability concern with some water-soluble compounds and high cost associated with softgel can impede the market growth.
The global enteric softgel capsules market is segmented based on application, sales channel, and region. Based on application, the market is classified as health supplements and pharmaceuticals. According to the sales channel, the market is segmented into supermarket & hypermarket, pharmacy & drug store, and online provider. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Key Benefits for Enteric Softgel Capsules Market:
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
- A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
Enteric Softgel Capsules Key Market Segments:
By Application
- Health Supplements
- Pharmaceuticals
By Sales Channel
- Supermarket & Hypermarket
- Pharmacy & Drug Store
- Online Provider
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
List Of Key Players Profiled in the Report
- BASF SE,
- Catalent, Inc.
- Colorcon Inc.
- Fuji Capsules Co. Ltd.
- InovoBiologic Inc.
- NOW Foods Inc.
- Sirio Pharma Co., Ltd.
- Super Spectrim
- Thermo Fisher Scientific, Inc. (Patheon)
- Trigen Laboratories, Inc.
List Of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request.)
- Nature's Way Products, LLC.
- Lonza Group Ltd
- PROCAPS (softigel)
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top player positioning
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Surge in adoption of softgel capsules
3.3.1.2. Rapid growth of e-commerce
3.3.1.3. Surge in healthcare expenditure worldwide
3.3.2. Restraints
3.3.2.1. Poor demand in under developed countries
3.3.3. Opportunities
3.3.3.1. Growth opportunities in emerging markets
3.3.4. Impact analyses
CHAPTER 4: ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Health supplements
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Pharmaceuticals
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
CHAPTER 5: ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL
5.1. Overview
5.1.1. Market size and forecast
5.2. Supermarket & hypermarket
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Pharmacy & drug store
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Online Provider
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
CHAPTER 6: ENTERIC SOFTGEL CAPSULES MARKET BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. enteric softgel capsules market, by application
6.2.2.1.2. U.S. enteric softgel capsules market, by sales channel
6.2.2.2. Canada
6.2.2.2.1. Canada enteric softgel capsules market, by application
6.2.2.2.2. Canada enteric softgel capsules market, by sales channel
6.2.2.3. Mexico
6.2.2.3.1. Mexico enteric softgel capsules market, by application
6.2.2.3.2. Mexico enteric softgel capsules market, by sales channel
6.2.3. North America enteric softgel capsules market, by application
6.2.4. North America enteric softgel capsules market, by sales channel
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany enteric softgel capsules market, by application
6.3.2.1.2. Germany enteric softgel capsules market, by sales channel
6.3.2.2. France
6.3.2.2.1. France enteric softgel capsules market, by application
6.3.2.2.2. France enteric softgel capsules market, by sales channel
6.3.2.3. UK
6.3.2.3.1. UK enteric softgel capsules market, by application
6.3.2.3.2. UK enteric softgel capsules market, by sales channel
6.3.2.4. Italy
6.3.2.4.1. Italy enteric softgel capsules market, by application
6.3.2.4.2. Italy enteric softgel capsules market, by sales channel
6.3.2.5. Spain
6.3.2.5.1. Spain enteric softgel capsules market, by application
6.3.2.5.2. Spain enteric softgel capsules market, by sales channel
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe enteric softgel capsules market, by application
6.3.2.6.2. Rest of Europe enteric softgel capsules market, by sales channel
6.3.3. Europe enteric softgel capsules market, by application
6.3.4. Europe enteric softgel capsules market, by sales channel
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan enteric softgel capsules market, by application
6.4.2.1.2. Japan enteric softgel capsules market, by sales channel
6.4.2.2. China
6.4.2.2.1. China enteric softgel capsules market, by application
6.4.2.2.2. China enteric softgel capsules market, by sales channel
6.4.2.3. Australia
6.4.2.3.1. Australia enteric softgel capsules market, by application
6.4.2.3.2. Australia enteric softgel capsules market, by sales channel
6.4.2.4. India
6.4.2.4.1. India enteric softgel capsules market, by application
6.4.2.4.2. India enteric softgel capsules market, by sales channel
6.4.2.5. South Korea
6.4.2.5.1. South Korea enteric softgel capsules market, by application
6.4.2.5.2. South Korea enteric softgel capsules market, by sales channel
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific enteric softgel capsules market, by application
6.4.2.6.2. Rest of Asia-Pacific enteric softgel capsules market, by sales channel
6.4.3. Asia-Pacific enteric softgel capsules market, by application
6.4.4. Asia-Pacific enteric softgel capsules market, by sales channel
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil enteric softgel capsules market, by application
6.5.2.1.2. Brazil enteric softgel capsules market, by sales channel
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia enteric softgel capsules market, by application
6.5.2.2.2. Saudi Arabia enteric softgel capsules market, by sales channel
6.5.2.3. South Africa
6.5.2.3.1. South Africa enteric softgel capsules market, by application
6.5.2.3.2. South Africa enteric softgel capsules market, by sales channel
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA enteric softgel capsules market, by application
6.5.2.4.2. Rest of LAMEA enteric softgel capsules market, by sales channel
6.5.3. LAMEA enteric softgel capsules market, by application
6.5.4. LAMEA enteric softgel capsules market, by sales channel
6.6. BASF SE
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product Portfolio
6.6.5. Business performance
6.7. Catalent, Inc.
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product Portfolio
6.7.5. Business performance
6.8. Colorcon, Inc.
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product Portfolio
6.9. Fuji Capsules Co., Ltd.
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Product Portfolio
6.10. Procaps
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product Portfolio
6.11. NOW Foods Inc.
6.11.1. Company overview
6.11.2. Company snapshot
6.11.3. Operating business segments
6.11.4. Product Portfolio
6.12. Thermo Fisher Scientific, Inc. (Patheon)
6.12.1. Company overview
6.12.2. Company snapshot
6.12.3. Operating business segments
6.12.4. Product Portfolio
6.12.5. Business performance
6.12.6. Key strategic moves and developments
6.13. Sirio Pharma Co., LTD
6.13.1. Company overview
6.13.2. Company snapshot
6.13.3. Operating business segments
6.13.4. Product Portfolio
6.14. Super Spectrim
6.14.1. Company overview
6.14.2. Company snapshot
6.14.3. Operating business segments
6.14.4. Product Portfolio
6.15. Trigen Laboratories, Inc.
6.15.1. Company overview
6.15.2. Company snapshot
6.15.3. Operating business segments
6.15.4. Product Portfolio
LIST OF TABLES
TABLE 01. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 02. HEALTH SUPPLEMENTS ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 03. PHARMACEUTICALS ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 04. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 05. SUPERMARKETS & HYPERMARKETS ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 06. PHARMACY & DRUG STORE ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 07. ONLINE PROVIDERS ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 08. ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 20172025 ($MILLION)
TABLE 09. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 10. U.S. ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 11. U.S. ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 12. CANADA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 13. CANADA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 14. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 15. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 16. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 17. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 18. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 19. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 20. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 21. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 22. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 23. UK ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 24. UK ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 25. ITALY ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 26. ITALY ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 27. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 28. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 29. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 30. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 31. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 32. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 33. ASIA- PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 34. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 35. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 36. CHINA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 37. CHINA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 38. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 39. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 40. INDIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 41. INDIA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 42. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 43. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 44. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 45. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 46. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 47. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 48. LAMEA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 49. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 50. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 51. SAUDI ARABIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 52. SAUDI ARABIA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 53. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 54. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 55. REST OF LAMEA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 56. REST OF LAMEA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 57. LAMEA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 58. LAMEA ENTERIC SOFTGEL CAPSULES MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 59. BASF SE: COMPANY SNAPSHOT
TABLE 60. BASF SE: OPERATING SEGMENTS
TABLE 61. BASF SE: PRODUCT PORTFOLIO
TABLE 62. CATALENT, INC.: COMPANY SNAPSHOT
TABLE 63. CATALENT, INC: OPERATING SEGMENTS
TABLE 64. CATALENT, INC.: PRODUCT PORTFOLIO
TABLE 65. COLORCON, INC.: COMPANY SNAPSHOT
TABLE 66. COLORCON, INC.: OPERATING SEGMENTS
TABLE 67. COLORCON, INC.: PRODUCT PORTFOLIO
TABLE 68. FUJI CAPSULES CO., LTD.: COMPANY SNAPSHOT
TABLE 69. FUJI CAPSULES CO., LTD.: PRODUCT PORTFOLIO
TABLE 70. PROCAPS.: COMPANY SNAPSHOT
TABLE 71. PROCAPS.: OPERATING SEGMENTS
TABLE 72. PROCAPS.: PRODUCT PORTFOLIO
TABLE 73. NOW FOODS: COMPANY SNAPSHOT
TABLE 74. NOW FOODS: OPERATING SEGMENTS
TABLE 75. NOW FOODS: PRODUCT PORTFOLIO
TABLE 76. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 77. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 78. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 79. SIRIO PHARMA CO., LTD.: COMPANY SNAPSHOT
TABLE 80. SIRIO PHARMA CO., LTD.: OPERATING SEGMENTS
TABLE 81. SIRIO PHARMA CO., LTD.: PRODUCT PORTFOLIO
TABLE 82. SUPER SPECTRIM.: COMPANY SNAPSHOT
TABLE 83. SUPER SPECTRIM: OPERATING SEGMENTS
TABLE 84. SUPER SPECTRIM: PRODUCT PORTFOLIO
TABLE 85. TRIGEN LABORATORIES, INC..: COMPANY SNAPSHOT
TABLE 86. TRIGEN LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 87. TRIGEN LABORATORIES, INC.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. ENTERIC SOFTGEL CAPSULES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS IN THE GLOBAL ENTERIC SOFTGEL CAPSULES MARKET
FIGURE 03. TOP PLAYER POSITIONING, 2017
FIGURE 04. IMPACT ANALYSES
FIGURE 05. COMPARATIVE ANALYSIS OF HEALTH SUPPLEMENTS ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 06. COMPARATIVE ANALYSIS OF PHARMACEUTICALS ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 07. COMPARATIVE ANALYSIS OF SUPERMARKET & HYPERMARKET ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 08. COMPARATIVE ANALYSIS OF PHARMACY & DRUG STORE ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 09. COMPARATIVE ANALYSIS OF ONLINE PROVIDER ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 10. BASF SE: REVENUE, 20152017 ($MILLION)
FIGURE 11. BASF SE: REVENUE SHARE BY BUSINESS SEGMENT, 2017 (%)
FIGURE 12. BASF SE: REVENUE SHARE BY GEOGRAPHIC SEGMENT, 2017 (%)
FIGURE 13. CATALENT, INC.: REVENUE, 20152017 ($MILLION)
FIGURE 14. CATALENT, INC.: REVENUE SHARE BY BUSINESS SEGMENT, 2017 (%)
FIGURE 15. CATALENT, INC: REVENUE SHARE BY GEOGRAPHIC SEGMENT, 2017 (%)
FIGURE 16. THERMO FISHER SCIENTIFIC: REVENUE, 20152017 ($MILLION)
FIGURE 17. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY SEGMENTS, 2017 (%)
FIGURE 18. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
